全文获取类型
收费全文 | 1391篇 |
免费 | 87篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 42篇 |
妇产科学 | 22篇 |
基础医学 | 145篇 |
口腔科学 | 72篇 |
临床医学 | 192篇 |
内科学 | 241篇 |
皮肤病学 | 19篇 |
神经病学 | 64篇 |
特种医学 | 165篇 |
外科学 | 137篇 |
综合类 | 31篇 |
预防医学 | 199篇 |
眼科学 | 10篇 |
药学 | 90篇 |
中国医学 | 1篇 |
肿瘤学 | 42篇 |
出版年
2021年 | 9篇 |
2019年 | 14篇 |
2018年 | 13篇 |
2017年 | 11篇 |
2016年 | 9篇 |
2015年 | 17篇 |
2014年 | 29篇 |
2013年 | 36篇 |
2012年 | 26篇 |
2011年 | 35篇 |
2010年 | 38篇 |
2009年 | 47篇 |
2008年 | 41篇 |
2007年 | 37篇 |
2006年 | 41篇 |
2005年 | 49篇 |
2004年 | 41篇 |
2003年 | 51篇 |
2002年 | 34篇 |
2001年 | 32篇 |
2000年 | 30篇 |
1999年 | 31篇 |
1998年 | 31篇 |
1997年 | 44篇 |
1996年 | 52篇 |
1995年 | 35篇 |
1994年 | 29篇 |
1993年 | 41篇 |
1992年 | 16篇 |
1991年 | 27篇 |
1990年 | 26篇 |
1989年 | 26篇 |
1988年 | 25篇 |
1987年 | 37篇 |
1986年 | 33篇 |
1985年 | 23篇 |
1984年 | 12篇 |
1983年 | 14篇 |
1982年 | 21篇 |
1981年 | 12篇 |
1980年 | 12篇 |
1978年 | 10篇 |
1977年 | 13篇 |
1976年 | 14篇 |
1975年 | 8篇 |
1974年 | 8篇 |
1929年 | 17篇 |
1928年 | 8篇 |
1924年 | 8篇 |
1922年 | 9篇 |
排序方式: 共有1487条查询结果,搜索用时 343 毫秒
1.
D Gröne† R Treudler† EM de Villiers‡ R Husak† CE Orfanos† ChC Zouboulis†§ 《Journal of the European Academy of Dermatology and Venereology》2006,20(2):202-205
Cidofovir is an acyclic nucleoside phosphonate with broad-spectrum activity against DNA viruses, including human papilloma virus (HPV). However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory. We report for the first time on the promotion of the healing of recalcitrant warts in a patient with myelodysplastic syndrome with intravenous cidofovir treatment. 相似文献
2.
3.
目的:观察开道散合扶正和胃合剂治疗上消化道癌性狭窄的临床疗效。方法:对40例患者采用口服开道散、扶正和胃合剂联合胃镜下癌灶内注射5-氟脲嘧啶注射液及鸦胆子乳剂方法治疗上消化道癌性狭窄。结果:治疗后无瘤灶消失病例,34例患者肿瘤缩小达50%以上,完全缓解0例,部分缓解34例,稳定4例,进展2例,有效率为85.0%。治疗后患者吞咽困难有了较明显的改善,显效7例,有效31例,无效2例,总有效率95.0%。治疗后所有患者的卡氏评分均有所升高,与治疗前比较,差异有显著性意义(P〈0.05),提示治疗后患者的生活质量有所改善。结论:开道散合扶正和胃合剂治疗上消化道癌性狭窄疗效满意,能使实体瘤缩小、吞咽困难改善、生活质量提高。 相似文献
4.
5.
E. Winslow J. K. Campbell L. Delbressine 《The Journal of pharmacy and pharmacology》1995,47(7):608-613
Org 20781, the major metabolite of Org 7797 found in in-vitro experiments was examined for antiarrhythmic and electrophysiological effects in-vivo. Org 20781 (0·5–2·0 mg kg?1 i.v.) inhibited the development of early ischaemia-induced arrhythmias in rats, suppressed spontaneous ventricular tachycardia (VT) in conscious dogs with 24-h old infarcts, and prevented electrical induction of VT in dogs with 5–6-day old infarcts, actions associated with slowing of conduction at all levels of the myocardium. Cardiac refractory periods were only modestly prolonged whilst repolarization was unchanged. Peak plasma levels of the parent compound (infused to total doses of 2–4mg kg?1) associated with suppression of late arrhythmias were 6–18 μm, whilst the mean plasma elimination half-life (in normal dogs) was 107 min. It was concluded that the major metabolite has a similar antiarrhythmic and electrophysiological profile to the parent compound, is at least half as potent and may contribute to the therapeutic effects of Org 7797 administration. 相似文献
6.
7.
Digital radiography of subtle pulmonary abnormalities: an ROC study of the effect of pixel size on observer performance 总被引:3,自引:0,他引:3
Forty conventional radiographs with examples of mild interstitial infiltrates and subtle pneumothoraces and 40 normal studies of the chest were selected and digitized, with pixel sizes of 1.0, 0.5, 0.2, and 0.1 mm. Observer performance tests were carried out using receiver operating characteristic analysis. Conventional radiographs and digitized images were compared. The results indicate that, in such cases, diagnostic accuracy increases significantly as the pixel size is reduced, at least to the 0.1-mm level. We conclude that, for digital systems using screen-film or similar image receptors, use of a pixel size substantially larger than 0.1 mm may result in some loss of diagnostic accuracy. 相似文献
8.
9.
J K Campbell R T Logan R J Marshall G McGarry T Sleigh E Winslow 《Journal of medicinal chemistry》1986,29(2):244-250
The antiarrhythmic efficacy of 17 beta-amino- and 17 beta-amino-16 alpha-hydroxyestratrien-3-ols and 3-acetates (group 1) was compared with the efficacy of corresponding 3-[2-hydroxy-3-(isopropylamino)propyl] and 3-[2-hydroxy-3-(tert-butylamino)propyl] ethers (group II), substituents which are usually associated with beta-adrenoceptor blocking activity. Group I compounds exerted potent antiarrhythmic activity against both aconitine-induced arrhythmias in mice and ischemia-induced arrhythmias in rats and reduced the maximum following frequency of isolated guinea pig atria. Electrophysiological studies indicated that their mechanism of action is due to an ability to reduce the fast inward sodium current in cardiac cells (class I antiarrhythmic action). Group II compounds were inactive in the aconitine and atrial tests and electrophysiological studies confirmed that they were devoid of class I activity. However, these compounds, like both class I antiarrhythmic and beta-adrenoceptor blocking drugs, were active against ischemia-induced arrhythmias. Group II compounds, unlike group I compounds, exerted nonspecific beta-adrenoceptor blocking actions, which may account for their activity in the rat test. It was concluded that introduction of the 3-substituted ether group did not confer any advantage over the parent 3-ol or 3-acetate compounds. 相似文献
10.